Table 2.
HMPV positive (%) |
HMPV negative (%) |
P value | |
---|---|---|---|
Age, median [IQR] | 5.8 [2.6–10.0] | 3.4 [1.6–8.4] | <0.001 |
Gender, male | 157 (57.5) | 1755 (60.6) | 0.31 |
Admission diagnosis | |||
Asthma | 14 (5.1) | 132 (4.6) | 0.67 |
Bronchiolitis | 56 (20.5) | 491 (17.0) | 0.14 |
Bronchopneumonia | 123 (45.1) | 897 (31.0) | <0.001 |
Pneumonia | 37 (13.6) | 357 (12.3) | 0.56 |
Rule-out sepsis | 34 (12.5) | 866 (29.9) | <0.001 |
Chronic medical conditions | 25 (9.2) | 296 (10.2) | 0.59 |
Gestational age, median, weeks [IQR] | 40 [38–40] | 40 [38–40] | 0.68 |
Number of siblings, median [IQR] | 2 [1–3] | 2 [1–3]a | 0.76 |
Daycare | 5 (1.8) | 45 (1.6)a | 0.43 |
Smoke exposure | 212 (77.7) | 2213 (76.4) | 0.65 |
Antibiotics prior to hospitalization | 142 (52%) | 1144 (39.5%) | <0.01 |
Antibiotics during hospitalizations | 253/271 (93.4%) | 2638/2876 (91.7%) | 0.35 |
Total patients: HMPV positive (273), HMPV negative (2895); p<0.01 is significant n=2894